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Background: Alkaptonuria (AKU) is an inborn error of catabolism due to a deficient activity of homogentisate
1,2-dioxygenase. Patients suffer from a severe arthropathy, cardiovascular and kidney disease but other organs
are affected, too. We found secondary amyloidosis as a life-threatening complication in AKU, thus opening
new perspectives for its treatment. We proved that methotrexate and anti-oxidants have an excellent efficacy
to inhibit the production of amyloid in AKU model chondrocytes. Owing to the progressive and intractable
condition, it seems important to detect amyloid deposits at an early phase in AKU and the choice of specimens for a
correct diagnosis is crucial.
Methods: Ten AKU subjects were examined for amyloidosis; abdominal fat pad aspirates, labial salivary gland, cartilage
and synovia specimens were analysed by CR, Th-T, IF, TEM.
Results: Amyloid was detected in only one abdominal fat pad specimen. However, all subjects demonstrated amyloid
deposition in salivary glands and in other organ biopsies, indicating salivary gland as the ideal specimen for early
amyloid detection in AKU.
Conclusions: This is, at the best of our knowledge, the first report providing correct indications on the diagnosis of
amyloidosis in AKU, thus offering the possibility of treatment of such co-morbidity to AKU patients.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
13000_2014_185
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Amyloidosis is the deposition of insoluble protein aggregates
either systemically or in a specific organ. Secondary (AA)
amyloidosis is caused by a chronic infection or chronic in-
flammatory disease where deposits are made up of serum
amyloid A (SAA) produced during inflammation.
We found SAA amyloidosis as a life-threatening compli-
cation in alkaptonuria (AKU) [1], an ultra-rare (1:250.000-
1.000.000 incidence) autosomal recessive genetic disease
due to a deficient activity of homogentisate 1,2-dioxygen-
ase (HGD) leading to the accumulation of homogenti-
sic acid (HGA). HGA-oxidized derivative benzoquinone
acetic acid (BQA) forms deposits in the connective tissue,
causing a pigmentation known as “ochronosis”, leading to
dramatic organ damage. A severe form of arthropathy is* Correspondence: annalisa.santucci@unisi.it
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unless otherwise stated.the most common clinical presentation of AKU, but all
the organs can be affected, too. AKU can be treated symp-
tomatically during the early stages, whereas for end stages
total joint and heart valve replacements may be required.
Currently, there is no therapy for AKU, although a clinical
trial with nitisinone is in progress.
AA amyloidosis is one of the most severe complica-
tions of several chronic rheumatic disorders [2,3] and is
a secondary complication of AKU due to a chronic in-
flammatory status derived from HGA/BQA-induced oxi-
dative stress [4-12]. SAA-amyloid in AKU co-localizes
with ochronotic pigment [1], AKU is a complicated in-
flammatory multisystemic disease, and any body district
expressing HGD may be affected [13].
Our findings on AKU as a novel AA amyloidosis opened
new perspectives for its treatment. In fact, the suppression
of SAA below 10 mg/L halts the progression of the disease
and is associated with prolonged survival, reversal of
amyloid deposition and recovery of organ function [14].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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excellent efficacy to inhibit the production of amyloid in
AKU model chondrocytes, suggesting their introduction
in AKU therapy.
Owing to AKU progressive and intractable condition,
it is crucial to detect amyloid deposits at an early phase.
As ascertained in other secondary amyloidosis, if SAA
deposition cannot be stopped or delayed, serious life-
threatening problems can arise [14]. Therefore, SAA
amyloidosis should be diagnosed as early as possible and
the clinicians treating AKU patients need an easy rou-
tine reproducible fast procedure that can be repeated at
intervals.
In this work, ten AKU subjects were examined for
amyloidosis in abdominal fat pad aspirates and labial sal-
ivary gland (LSG) biopsies. Amyloid was detected in only
one abdominal fat pad specimen. However, all subjects
demonstrated amyloid deposition in LSGs and in other
organ biopsies. These results further support the con-
cept that LSG may be the optimal specimen for early de-
tection of amyloid in AKU and that LSG offers
improved sensitivity in respect to fat pad aspirates in
these patients.
This is, at the best of our knowledge, the first report
providing correct indications on the diagnosis of amyl-
oidosis in AKU, thus offering the possibility of treatment
of such co-morbidity to AKU patients.
Methods
Procedures were approved by Siena University Hospital and
national Ethics (Comitato Etico Policlinico Universitario di
Siena, number GGP10058, date 21/07/2010) in accordance
with 1975 Helsinki Declaration, revised in 2000 (52nd
WMA General Assembly, Edinburgh, Scotland, October
2000). Informed consent was obtained from all patients.
All reagents were from Sigma-Aldrich (St. Louis, MO),
if not differently specified.
LSG
After reviewing AKU patients’ medical history and la-
boratory values (Table 1 and 2), a clinical examination
was completed and each subject underwent two biopsies
of clinically normal-appearing tissue in the oral cavity
under local anesthesia (2% lidocaine with 1:100,000 epi-
nephrine). Specimen 1 was taken from the left lateral sur-
face of the tongue, containing mucosal and muscle tissue.
Specimen 2 was taken from the labial mucosa on the left
side of the lower lip, containing at least 2 to 3 minor saliv-
ary glands. Both specimens were formalin fixed and ana-
lyzed for histopathologic evaluation of amyloid.
Abdominal fat
Patients underwent a subcutaneous abdominal fat biopsy
via fine-needle aspiration. Skin and subcutaneous tissuearound the umbilicus of the patients were anesthetized
with 1% lidocaine. The fat was aspirated with an 18-
gauge needle connected to a 20 ml syringe. At least two
visible fragments of fat were placed on a glass slide and
crushed into a single layer by pressing a second slide
against the first. After the smears were dried in air at 50°C
for at least 30 minutes and fixed with 20% formalin neu-
tral buffer solution (Wako Pure Chemical, Osaka, Japan)
for 5 minutes, these specimens were processed for the
Congo Red staining.
Cartilage and synovia
Articular cartilage fragments, from AKU subjects who
underwent surgery for joint replacement, were placed in
5% formaldehyde. Samples were alcohol dehydrated and
paraffin embedded.
Aortic valve
Valve was obtained from an AKU subject who under-
went biologic aortic valve replacement.
Prostatic calculus
The stone was from the prostate gland of an AKU subject
who underwent surgical exploration for calculus removal.
Hematoxylin and Eosin (H&E) staining
Two sections (5 μm thickness) were obtained from each
biopsy. Sections were stained with traditional hematoxylin/
eosin (H/E) staining.
Congo Red (CR) staining
Romhányi’s CR staining method modified according to
Bély and Apáthy (2000) was adopted. 5 μm sections of
fresh specimen were fixed in cooled 96% ethanol
10 min, rinsed in water, incubated in 1% CR for 40 min,
washed in water, incubated 10 s in 1 mL 1% sodium hy-
droxide in 100 mL of 50% ethanol, incubated 30 s in
Mayer's hematoxylin, sequentially washed in 50%, 75%,
95% ethanol, mounted and observed under a polarized
light microscope (Zeiss Axio Lab.A1, Arese, Milano).
Thioflavin T (Th-T) staining
AKU LSG samples incubated in 1% Th-T [15,16] were
mounted and observed under a fluorescence microscope
(excitation 450 nm, emission 482 nm).
Fluorescence microscopy
AKU samples in paraffin were cut in 3–5 μm slices and
double immunofluorescence stained with anti-SAA and
anti-serum amyloid P (SAP) antibodies (Santa Cruz Bio-
technology, CA). Nuclei were counter-stained with blue
DAPI DNA stain (Abcam, Cambrige, UK).
Table 1 Alkaptonuria patients enrolled for the study and their characteristics
Features Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10
Age (years) 71 60 63 42 60 58 42 38 65 55
Sex F F F F M M M F F F
Serology
SAA mg/L 117.70 87.14 97.44 18.16 25.35 25.44 25.13 16.13 28.46 69.90
HGA plasma level μmol/L 31.10 72.90 20.56 15.80 17.02 22.43 18.95 15.21 31.76 13.42
HGA urine level mmol/L 23.70 16.90 22.64 21.70 22.30 18.64 24.10 12.68 22.76 16.60
Congo Red birefringence score
Abdominal fat n.d. - - - - - - - n.d. +
Salivary gland +++ ++ ++ ++ ++ +++ ++ +++ ++ ++
Synovia +++
Cartilage +++ +++
Aortic valve +++ +++
Prostatic stone ++
ThT fluorescence (+/−)






Salivary gland positive positive positive positive positive positive positive positive positive positive
Synovia positive positive positive positive









TEM Amyloid abundance score
+++ +++ ++ +++ +++ +++ ++ +++ ++ +
F: female, M: male, n.d.: not determined. The patients were classified on the basis of Congo red intensity of staining (grades: +++, very intensive; ++, intensive; +,
weak; −, no birefringence). The presence of amyloid deposits in LSG observed at TEM was evaluated as: +++ = very abundant, ++ =medium; + = faint. Positivity
for ThT fluorescence and SAA and SAP immunohistology is also reported.
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AKU specimens were fixed in 2.5% glutaraldehyde in
0.1 M cacodylate buffer (CB) pH 7.2 for 3 h at 4°C, post-
fixed in 1% osmium tetroxide in CB for 2 hours at 4°C,
ethanol dehydrated and embedded in a mixture of Epon–
Araldite resins. Thin sections, obtained with a Reichert
ultramicrotome, were stained with uranyl acetate and
lead citrate and observed with a TEM FeiTecnai G2
spirit at 80 Kv.Results
Structural features of AKU salivary glands were first
evaluated by means of H&E staining (representative im-
ages are presented in Figure 1A-B). Parenchyma was
found to be compact only in some limited areas; by con-
trast, a number of vacuoles and a disrupted acinar struc-
ture were present in the vast majority of the specimen.
All of the AKU salivary glands that were examined did
not contain any trace of lymphocytic infiltration.
Table 2 Clinical features of AKU patients









1 08/2011 y y y n y y Knee (r), shoulder (r) and hip (l) arthroplasty
2 10/2009 y y n y y n Knee (r, l), shoulder (r) and hip (r) arthroplasty
3 03/2012 n y n n y n Meniscus (r) surgical repair
4 04/2012 y y n n n n None
5 11/2012 y y n y y n Knee (l), and hip (l) arthroplasty
6 01/2013 y n n y y n Knee (r) arthroplasty
7 05/2012 n y n n n n None
8 02/2012 y y y n y n Knee (l) arthroplasty
9 03/2013 y n y y y y Knee (r) and tendon ankle fracture (l)
10 11/2011 y y n n y y Knee (r), and hip (l) arthroplasty
















Figure 1 H/E staining of AKU salivary gland. Some striated ducts
(arrowheads), secretory acini (white arrows) and red blood cells
(black arrows) are indicated. Only representative images are shown.
Magnification: A: 20×; B: 40 × .
Figure 2 Evidence of amyloid deposits in AKU salivary glands.
A) Congo Red staining of AKU labial salivary glands amyloid deposits.
CR stain viewed under polarized light detected the presence of
diffuse amyloid deposits within AKU salivary gland tissue.
Magnification 20×. Representative images from a triplicate set are
shown. B) Th-T fluorescence of AKU labial salivary glands amyloid
deposits shown by confocal microscopy. Analogous results were
obtained from specimens of other patients. Bar: 22 μm.
Representative images from a triplicate set are shown.
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diagnostic laboratories adopted periumbelical fat aspirate
CR staining [17] that unfortunately proved to be unsuit-
able for the detection of amyloid deposits in AKU pa-
tients. Indeed, we studied abdominal fat pad aspirates
and labial salivary gland biopsies from 10 AKU patients
in whom subsequent other tissue biopsies for confirm-
ation of AA amyloidosis were also available. All cases
were suspected to have SAA deposits, but nine of them
had negative results on abdominal fat pad aspirates
evaluated by polarizing microscopy of CR stained sec-
tions (not shown). CR staining of fat aspirates from
three different hospital laboratories were compared in
all samples for studying inter observer reproducibility
and gave negative diagnosis of amyloidosis in nine
cases out of ten.
Once CR staining was adopted on AKU LSGs, the results
were unequivocally positive for all ten patients (Figure 2A).
To confirm the presence of amyloid aggregates in LSG
from AKU patients, we performed the Th-T assay. Th-T
fluorescence was evident in all examined samples (10/10)
Millucci et al. Diagnostic Pathology 2014, 9:185 Page 6 of 9
http://www.diagnosticpathology.org/content/9/1/185(Figure 2B). Moreover, by means of immunofluorescence
techniques, we assessed the presence of SAA deposition
in LSG (Figure 3).
Ultrastructural analysis by TEM of AKU LSGs (the
current ‘gold standard’ for detecting amyloid deposits
also in ambiguous cases), confirmed the massive pres-
ence of amyloid fibrils in all specimens. Amyloid de-
posits in LSG were abundant in six patients, moderate
in three, and mild in one (Table 1). Figure 4 shows fine
fibrils, approximately 10 nm in diameter, located in the
secretory stroma of AKU salivary glands of patient #1,
adjacent to the basement membrane. The fibrils were
also present in the interstitial connective tissue, inter-
spersed with collagen fibrils (Figure 4A) and around
interlobular ducts of salivary glands of all patients. In all
observed samples, the glandular stroma contained nu-
merous broken collagen fibrils strictly interconnectedFigure 3 SAA and SAP in AKU salivary glands. A)
Immunofluorescence staining of SAA deposition in AKU labial
salivary glands. Blue indicates DAPI stained nuclei. Magnification
20×. Representative images from a triplicate set are shown. B)
Immunofluorescence staining of SAP deposition in AKU labial
salivary glands. Magnification 20×. Representative images from a
triplicate set are shown.
Figure 4 Electron micrographs of AKU salivary glands. A)
Electron micrograph showing fine amyloid fibrils (A) approximately
10 nm in diameter located in close relation to the lamina (LP) of the
secretory end-pieces as well as in the interstitial connective tissue
stroma of AKU labial salivary gland. Pigment granules are visible
amongst collagen fibrils in transverse and longitudinal section (black
arrows). B-C) Electron micrographs of another AKU labial salivary
gland showing a region of the interstitial glandular stroma that
contains fine amyloid fibrils (A), approximately 10 nm in diameter,
interspersed with bundles of collagen fibrils (C). Pigment deposits
are present on broken collagen fibers (black arrows) and scattered
between amyloid fibrils. To be note that amyloid fibrils appear
superimposed to collagen fibers in different area of the tissue.
D-F) Electron micrograph of a third AKU labial salivary gland showing
the glandular stroma containing finely fibrillar amyloid material (A).
In photo E) collagen fibers in transverse section are shown (arrowheads),
many of which presenting electron dense ochronotic deposits located
amongst fibers. In photos E-F), dark ochronotic pigment granules are
indicated (arrowheads) scattered amongst the collagen fiber as well as
amongst amyloid fibrils. Some deposits can be observed located within
amyloid bundles of fibrils and bridging between collagen fibers (white
arrows). A: amyloid; C: collagen; LP lamina propria. Photo A is from
patient #2, photos B-C are from patient #5 and photos D-F are from
patient #7. Bars, A: 5 μm, B, C and E: 2.5 μm, D and F: 1 μm.with amyloid fibrils arranged in a scattered manner. More-
over, thanks to TEM analysis, it was possible to see evi-
dent pigment traces finely sprinkled over the whole tissue
(Figure 4B-F). In particular, pigment deposits could be
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gen fibers and also scattered over amyloid bundles of
fibrils.
Our study showed, for the first time, that, analogously
to other AKU tissues [1,9], also in LSG amyloid and pig-
ment were strictly interconnected and that collagen fibrils
seemed to feel the effect of destructive action of both pig-
ment and amyloid, appearing constantly broken and dam-
aged when sprinkled and invaded by these two elements.
The presence of ochronotic pigmentation in less commonlyFigure 5 Confirmation of amyloidosis in other AKU tissues. A) Positive
and prostatic stone. B) TEM observation of amyloid deposits in cartilage (leexamined areas of human body, such as glandular tissues,
may provide insights into the mechanisms of pigment for-
mation and deposition. Here, we presented evidence to
support the probable association of HGA oxidised prod-
ucts with collagen and the existence of extracellular mech-
anisms, like as amyloid deposition, mediating ochronotic
pigmentation that overlaps in tissues.
Confirmatory evaluation of SAA- and SAP-amyloid co-
presence (Figure 5A) and TEM observation of amyloid fi-
brils (Figure 5B) in other AKU specimens was possible.staining for SAA-and SAP-amyloid in cartilage, synovia, aortic valve
ft image: bar 500 nm) and aortic valve (right image: bar 50 nm).
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The tissue source impacts the likelihood of discovering
amyloid deposits. Bone marrow biopsy sensitivity has
been estimated at 63% [18]. Kidney, liver, or cardiac bi-
opsies have sensitivity as high as 87–98% but are more
invasive [18]. Rectal biopsy sensitivity ranges from 69%
to 97% depending upon the quantity of tissue sampled.
Tissue source also impacts amyloid typing. The chemical
type of amyloid that deposits in AKU is amyloid A pro-
tein and since this type of amyloid involves diffusely the
mucosa and the submucosa [19], it may be better to pre-
fer location as the oral cavity or gastrointestinal tract to
detect them. In particular, LSG biopsy is less invasive
and cheaper than examination of rectal mucosa. In the
last years, various studies have demonstrated the utility
of LSG biopsy for the detection of amyloid with correl-
ation to secondary systemic amyloidosis [20,21].
Amyloid deposition is a dynamic process that can pro-
gress and stabilize. Quantification of SAA concentration
in tissue on regular occasions will similarly reflect the
accumulation, stabilization or even regression of depos-
ited amyloid. Abdominal subcutaneous fat tissue seems
to be very suitable for this purpose [17,22], because it is
easy to obtain by aspiration, but, at least in some cases, it
has limited sensitivity and turned out inadequate [23-25].
In fact, subcutaneous abdominal fat CR staining is positive
in approximately 80% of patients with AL amyloidosis and
less than 65% of patients with AA amyloidosis [24]. Thus,
the negative result on staining of the abdominal-fat aspir-
ate in AKU cases does not necessarily indicate negativity
of amyloidosis at the diagnosis. Moreover, Tribe [26] did
not recommend the use of subcutaneous fat aspiration be-
cause he reported that “fat is rarely involved”. Libbey et al.
[17] reported a 20% false negative result rate. It thus
appears that abdominal fat aspiration is a method not
enough sensitive to detect AA in rheumatic diseases.
In all ten AKU samples, amyloid deposits were identi-
fied so underlining the high sensitivity of LSG biopsy in
the diagnosis of amyloidosis, even in the absence of
other symptoms.
Conclusions
LSG biopsy appears as a simple and safe method to de-
tect generalized amyloidosis in patients with a chronic
inflammatory disease such as AKU. The results of our
pilot study demonstrate that the prevalence of occult
amyloid deposition in patients with AKU may be very
high. Since a prompt detection of amyloid may have sig-
nificant clinical and economic implications in AKU, it is
fundamental to establish accurately the association of
synchronous amyloidosis. In our limited size sample,
due to ultra-rarity of the disease, the majority of AKU
patients had no detectable amyloid deposition on fat pad
aspirate. However, we were able to detect amyloiddeposition in minor LSG in all AKU patients. This sug-
gests that subclinical amyloid deposition may be more
easily detected on oral biopsies, and the oral cavity may
be the preferred biopsy site for detecting amyloid depos-
ition in AKU patients with no symptoms of systemic
amyloidosis.
Our study suggests that minor LSG, especially when
the biopsy of affected are lacking, may be the gold stand-
ard for the diagnosis of SAA amyloidosis in AKU.
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